Amber Salter, Ph.D.

Section Head, Statistical Planning & Analysis

Associate Professor

Endowed Title: Kenney Marie Dixon-Pickens Distinguished Professorship in Multiple Sclerosis Research
School: Medical School
Department: Neurology | Peter O'Donnell Jr. Brain Institute

Biography

Dr. Amber Salter is an Associate Professor of Biostatistics at UT Southwestern. She graduated from the University of Alabama at Birmingham with a PhD in Biostatistics in 2015 and has a MPH in Epidemiology. She holds joint appointments in the Department of Population and Data Sciences and the Peter O’Donnell Jr. Brain Institute.

Dr. Salter’s research interest are in the design, analysis and interpretation of clinical trials and epidemiologic studies with a heavy focus in the area of Multiple Sclerosis (MS). She is also interested in the design and analysis of large complex databases and the issues and implications of their use in practice. She has been conducting research in the disease area of MS for over 10 years, specifically working with a disease registry, the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry, which collects self-report data from persons with MS semi-annually.

Publications

Intermittent documentation of blood pressure values does not provide comprehensive evaluation of the hemodynamic response during continuous intravenous medication administration: Doyle BR, Nairon EB, Jones E, Salter A, Olson DW Scientific reports 2025 Dec 15
Strengthening older adults remembering (SOARing): Research protocol for a multi-site randomized clinical trial examining the efficacy of the Kessler Foundation modified story memory technique (KF-mSMT®) in mild cognitive impairment (MCI): Chiaravalloti ND, Weber E, Dobryakova E, Lengenfelder J, Tong TT, Mulhauser K, Moore NB, Robinson B, Maloku D, Salter A, Kanaan NM, Costa SL, Hampstead BM Contemporary Clinical Trials 2025 Jun 153
Perspectives of People With Multiple Sclerosis Regarding Data Linkage and Sharing: Marrie RA, Sharma M, Cutter GR, Fox RJ, Salter A Neurology 2025 Apr 104
Increased White Matter Aerobic Glycolysis in Multiple Sclerosis: Brier MR, Judge B, Ying C, Salter A, An H, Patel A, Wang Q, Wang Y, Cross AH, Naismith RT, Benzinger TL, Goyal MS Annals of Neurology 2025 Apr 97 766-778
PRESSURE GRADIENT AS A PREDICTOR OF TIME NEEDED TO DRAIN CEREBROSPINAL FLUID VIA AN EXTERNAL VENTRICULAR DRAIN: Olson DM, Nairon EB, Riskey LM, Salter A, Busch DR American Journal of Critical Care 2025 Mar 34 129-136
Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis: Salter A, Lancia S, Cutter GR, Fox RJ, Marrie RA Multiple Sclerosis Journal 2025 Mar 31 314-323
Does intracranial pressure vary based on external ventricular drainage? A real-world clinical observation study: Kwon D, Riskey L, Kamal A, Doyle BR, Louthen B, Marshall JL, Ruxmohan SD, Salter A, Olson DW Australian Critical Care 2025 Mar 38
High definition transcranial direct current stimulation as an intervention for cognitive deficits in Alzheimer's dementia: A randomized controlled trial: LoBue C, Chiang H, Salter A, McClintock S, Nguyen TP, Logan R, Smernoff EN, Pandya S, Hart J The journal of prevention of Alzheimer's disease 2025 Feb 12 100023
Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis: Salter A, Lancia S, Cutter GR, Fox RJ, Marrie RA Neurology 2025 Jan 104 e210149
The caregiver burden of idiopathic inflammatory myopathies: Brady P, Hernandez RS, Salter A, Hua C, Wilson L, Lubinus M, Hu YP, Nandakumar D, Bhashyam AR, Bhai S Quality of Life Research 2025